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Abstract Adenocarcinomas of the sinonasal tract may
originate from respiratory surface epithelium or the
underlying seromucinous glands. These malignancies are
divided into salivary-type adenocarcinomas and non-sali-
vary-type adenocarcinomas. The latter are further divided
into intestinal-type and nonintestinal-type adenocarcino-
mas. This review provides an update on tumor classifica-
tion, differential diagnostic considerations and molecular
features, as well as new adenocarcinoma entities in the
sinonasal area.
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Salivary-Type Adenocarcinomas
Sinonasal salivary-type carcinomas arise from the sero-
mucinous glands and surface epithelium of the nasal cavity
and paranasal sinuses [1]. They comprise 5–10 % of
sinonasal adenocarcinomas [2].
The histopathological appearances of these tumors are
for the most part similar to those of carcinomas and ade-
nomas arising in major and minor salivary glands. Most of
the tumor types that occur in major and minor glands also
occur in the sinonasal area, with the exception of Warthin
tumor and purely sebaceous salivary tumors [3]. Tumor
types include pleomorphic adenoma, myoepithelioma,
adenoid cystic carcinoma, mucoepidermoid carcinoma,
acinic cell carcinoma, myoepithelial carcinoma, epithelial-
myoepithelial carcinoma, salivary duct carcinoma, basal
cell adenocarcinoma, polymorphous low-grade adenocar-
cinoma, carcinoma ex-pleomorphic adenoma, adenocarci-
noma, NOS, and others. In the sinonasal tract, pleomorphic
adenoma is the most frequent salivary-type tumor [1].
Adenoid cystic carcinoma (AdCC) is the most common
salivary-type carcinoma, and the second most common
sinonasal malignancy overall after squamous cell carci-
noma, and it represents 10–18 % of all sinonasal malig-
nancies [2, 4] (Fig. 1). AdCC usually occurs in the
maxillary sinus or the nasal cavity [4]. Tumor type-specific
gene rearrangements such as MYB-NFIB have been
described in AdCC also in the sinonasal tract [5]. Long-
term prognosis of AdCC is poor due to local spread.
Mucoepidermoid carcinoma is less common representing
around 5 % of sinonasal glandular tumors [2, 6]. Acinic
cell carcinoma, epithelial-myoepithelial carcinoma, poly-
morphous low-grade adenocarcinoma, adenocarcinoma,
NOS, and others are even more rare. Furthermore, rare
sinonasal carcinomas have displayed both AdCC-like his-
tological features with surface squamous dysplasia and an
HPV-association (particularly of types 33 and 35), but not
the MYB gene rearrangement frequent in AdCC of other
organ sites [5].
Awareness of the possibility of salivary-type tumors in
the sinonasal tract is important when diagnosing neoplastic
lesions in this area. The differential diagnoses of salivary-
type carcinomas include intestinal-type adenocarcinoma
and nonintestinal-type adenocarcinoma. Furthermore, sali-
vary-type malignancies with clear cell features such as
hyalinizing clear cell carcinoma must be differentiated
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from renal cell carcinoma metastatic to the sinonasal tract.
On the other hand, differential diagnosis of a metastatic
renal cell carcinoma should also include the rare sinonasal
renal cell-like adenocarcinoma of the sinonasal tract [7].
The treatment of salivary-type tumors is complete sur-
gical removal. The 5-year survival rates have ranged from
40 to 60 %, with the poorest results in AdCC [3, 4].
Postoperative radiotherapy has been recommended.
(Non-salivary-Type) Surface Epithelial
Adenocarcinomas
The WHO classifies sinonasal adenocarcinomas of surface
epithelial origin in intestinal and nonintestinal types [8].
Intestinal-Type Adenocarcinoma
Intestinal-type adenocarcinoma (ITAC) is the second most
common type of sinonasal adenocarcinoma after AdCC. It
is composed of growth patterns that resemble carcinomas
or adenomas of intestinal origin, or it may mimic normal
histology of the intestinal mucosa [9, 10]. ITACs occur
mostly in males in a wide age range with a mean around 50
to 64 years. The tumors are most often localized in the
ethmoid sinus (40 %), followed by the nasal cavity (25 %)
and the maxillary antrum (20 %). ITACs are aggressive
malignancies, and may spread to adjacent structures
including the orbit, the pterygopalatine fossa, the
infratemporal fossa and the cranial cavity.
A remarkable association has been identified between
long-term exposure to wood dusts and the occurrence of
ITAC [11–15]. In woodworking industries, workers with
occupational exposure to hardwood dusts may show inci-
dences 1000 times those of the general population. Occu-
pational wood dust exposure has been observed in ca. 20 %
of cases. Interestingly, the highest incidences are seen in
woodworkers in the furniture industry where hardwoods,
particularly beech and oak, are used [13, 16]. Also, ITAC is
frequent in long-term wood dust exposure in woodworkers
who lay hardwood floors. Also, occupational exposure to
dusts in the shoe and leather industry [17] and in textile
manufacture, as well as to chromium and nickel, have been
incriminated [18]. The carcinogenic compounds have not
been identified, but a possible etiologic role for tannins has
been suspected [18]. The cumulative exposure time to
wood dusts in patients with ITAC has been 40–43 years
[9]. ITACs associated with dust exposure occur predomi-
nantly in the ethmoid sinus, while sporadic ITACs often
arise in the maxillary antrum.
ITACs mimic the appearance of the mucosa in normal
and neoplastic large and small intestine. Based on histo-
logic parameters, Barnes subdivided ITACs into five cat-
egories: papillary, colonic, solid, mucinous, and mixed
types [9]. The classification of Kleinsasser and Schroeder
[19] subdivides ITACs into papillary-tubular cylindrical
cell type (corresponding to papillary, colonic, and solid
types), alveolar goblet cell type, signet-ring cell type
(corresponding to mucinous type), and transitional cell type
(corresponding to mixed type). The histologic subtypes
have been found to correlate with clinical behavior [9, 18,
19].
The papillary type (ca. 18 % of ITACs) shows a
prominent papillary architecture with few tubular areas
(Fig. 2a). Tumors contain columnar goblet cells mimicking
intestinal adenomas (Fig. 2b). Occasionally, papillary
ITACs may recapitulate normal intestinal mucosa with
normal-looking villi, and with the specialized cell types
(goblet, resorptive, Paneth, and argentaffin cells) and the
muscularis mucosae [20].
The colonic type is the most frequent ITAC (40 %). It
displays glandular, tubular and trabecular architecture and
few papillae, and resembles a conventional colorectal
adenocarcinoma (Fig. 3). Crowded columnar cells with
variation in nuclear size and shape line the tumor glands.
Intra- and extracellular mucin and few goblet cells may be
seen. These tumors are often widely invasive. The solid
type comprises less differentiated ITACs with predomi-
nantly solid growth patterns. The mucinous type displays
mucin-filled glands, or cell clusters that float in pools of
extracellular mucin (Fig. 4) and often contain signet-ring
cells. Mucinous ITACs closely mimic the mucinous vari-
ants of colorectal adenocarcinoma. The mixed type con-
tains a mixture of the preceding types.
The immunophenotype of ITAC includes staining for
CK20 (Fig. 5a), CDX2 (Fig. 5b), villin, and MUC2, and
variable positivity for CK7 (Fig. 5c) [21–23]. Focal chro-
mogranin A (Fig. 5d) and synaptophysin may be seen in
the neuroendocrine cells. A subset of ITACs, mostly in
Fig. 1 Adenoid cystic carcinoma of nasal cavity. Classic cribriform
pattern with bland nuclear morphology. H–E stain 9400
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woodworkers, expressed high levels of EGFR protein [24].
In contrast to colorectal carcinomas, activating mutations
of K-RAS and BRAF in the signal route of EGFR are rare
[25–27]. This suggests possibilities for anti-EGFR
therapies in ITAC. Other molecular studies indicate pre-
served expression of mismatch repair proteins, b-catenin
and E-cadherin [28], and overexpression of MET protein
[29]. Annexin A1 and A2 were down-regulated in ITAC
[30]. High prevalence of TP53 mutations was seen in
sinonasal carcinoma with work-related exposure to wood
dust [31].
Differential diagnosis of ITAC includes metastatic gas-
trointestinal carcinoma and sinonasal low-grade nonin-
testinal adenocarcinoma. On grounds of histology and
immunophenotype, colonic or mucinous ITAC cannot be
distinguished with certainty from colorectal carcinoma
metastatic to the sinonasal tract. Both ITACs and colorectal
carcinomas express CK20, CDX-2, MUC2, and villin, while
the presence of CK7 may be suggestive of ITAC. However,
colonoscopy or colorectal radiographic studies should be
employed to rule out primary colorectal carcinoma in case of
an intestinal-type tumor in the sinonasal tract. Furthermore,
while CDX-2 is helpful for diagnosing ITAC, it is not
absolutely specific, as it can be expressed also in sinonasal
undifferentiated carcinomas and rarely in salivary-type
adenocarcinomas. More specific for ITAC than the expres-
sion of CDX-2 is the expression of CK20 [32].
The treatment of ITAC is surgical resection varying
from lateral rhinotomy and partial maxillectomy to total
maxillectomy. Surgery may be combined with
radiotherapy.
The behavior of ITAC is that of a high-grade malig-
nancy. In a study of 213 ITACs, 50 % of patients devel-
oped recurrences, 8 % had cervical lymph node metastases,
13 % had distant metastases, and 60 % died of their disease
[9]. Well differentiated papillary ITACs have an indolent
course, but patients with solid and mucinous ITACs have
an untoward outcome [9, 18, 19].
Fig. 2 a Intestinal-type adenocarcinoma, papillary growth pattern.
The pattern is composed of papillary projections and glandular and
tubular structures. H–E stain 9250. b Tumor of Fig. 3a. The nuclei
are elongated, irregular and often hyperchromatic. There is some
nuclear piling. Cellular form is mostly cylindrical. There are many
mitotic figures. H–E stain 9400
Fig. 4 Intestinal-type adenocarcinoma, mucinous growth pattern.
Clusters of tumor cells contain a few goblet-type cells, and are
suspended in a pool of Alcian Blue-positive mucin. Alcian-Blue PAS
stain 9400
Fig. 3 Intestinal-type adenocarcinoma, colonic growth pattern. Glan-
dular structures and some trabecular areas. High mitotic activity. H–E
stain 9250
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Nonintestinal-Type Adenocarcinoma
These adenocarcinomas display histopathologic features of
neither sinonasal intestinal-type adenocarcinomas nor
salivary-type adenocarcinomas, and they are divided in
high-grade and low-grade types [8].
High-grade nonintestinal-type adenocarcinomas are
rare malignancies of the sinonasal tract. Patients are fre-
quently males with a wide age range and a mean around
60 years. Histopathologically, these tumors have been
reported to display a diversity of morphologic patterns such
as blastomatous, apocrine, oncocytic/mucinous, poorly
differentiated/undifferentiated, and others [33]. Their
nuclei tend to be pleomorphic and there is mitotic activity
(Fig. 6). These tumors were reported to lack CDX-2 and
CK20 immunoreactivity [33]. The heterogeneous features
of these tumors may overlap with those of other malig-
nancies of this area, and consequently other primary and
metastatic malignancies must be carefully ruled out before
making this diagnosis. In particular, differential diagnosis
from salivary-type adenocarcinoma, NOS may be very
challenging. The prognosis of high-grade nonintestinal-
type adenocarcinomas is poor [33, 34].
Low-grade nonintestinal-type adenocarcinomas are
uncommon (13 % of sinonasal adenocarcinomas) and
occur mostly in the ethmoid sinus, the nasal cavity, and the
Fig. 5 Immunohistochemical staining of intestinal-type adenocarcinoma, papillary growth pattern, for a CK20, b CDX-2, c CK7, and
d chromogranin A. Peroxidase conjugated ABC Kit (Dako) 9250
Fig. 6 High-grade nonintestinal-type adenocarcinoma of nasal cav-
ity. This high-grade tumor is poorly differentiated and displays
atypical mitotic figures. It has areas of glandular differentiation, but
does not exhibit intestinal or salivary-type features. H–E stain 9400
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maxillary sinuses. The age range is wide with a mean of
37–53 years. Synonyms in the literature include terminal
tubulus adenocarcinoma [35], sinonasal tubulopapillary
low-grade adenocarcinoma [36, 37], sinonasal low-grade
adenocarcinoma [34], and sinonasal seromucinous adeno-
carcinoma [38]. These carcinomas have no known associ-
ation with environmental carcinogens.
Histopathologically, low-grade nonintestinal-type car-
cinomas exhibit varied architectural forms with exophytic
papillae and tubular or glandular patterns [36, 39, 40]
(Fig. 7). Trabecular, cribriform, clear cell and mucinous
patterns have also been reported. The papillae and glands
are usually lined by a single layer of uniform columnar or
cuboidal cells with only minor cytologic aberrations. They
show a bland low-grade cytology with round, uniform
nuclei and inconspicuous nucleoli (Fig. 8). Mitotic fig-
ures are very rare. In these bland tumors, complexity of the
growth pattern and local invasive growth are findings
supporting a diagnosis of malignancy. Immunohistochem-
ically, they are constantly positive for CK7, but usually
negative for CK20 and CDX-2. Some 20 % of these tumors
associate with sinonasal seromucinous hamartomas or
respiratory epithelial adenomatoid hamartomas [39, 41,
42]. Due to positivity for markers of seromucinous differ-
entiation such as DOG1, SOX10, and S-100, a subset of
these carcinomas was called sinonasal seromucinous ade-
nocarcinomas [42].
Differential diagnosis of low-grade nonintestinal-type
adenocarcinoma includes ITAC, acinic cell carcinoma,
oncocytic Schneiderian papilloma and, rarely, metastatic
papillary carcinoma of the thyroid. Differentiation of these
low-grade carcinomas from ITAC is highly important in
view of the distinct behaviors of the two neoplasms. The
defined growth patterns and high nuclear grade of ITAC
usually allow for a clear-cut differential diagnosis.
Immunohistochemically, low-grade nonintestinal-type
adenocarcinomas remain negative for CK20, CDX-2 and
MUC2. However, rare ITACs that resemble normal
intestinal mucosa may present a source of confusion. Even
such bland-looking ITACs are potentially high-grade
malignancies. Oncocytic Schneiderian papillomas may be
confused with low-grade nonintestinal-type adenocarcino-
mas although the epithelium of papillomas is multilayered
and does not contain true glandular lumina [34]. Metastatic
papillary carcinoma of the thyroid can be distinguished
with stains for TTF-1 and thyroglobulin.
The treatment of low-grade nonintestinal-type adeno-
carcinoma is complete surgical removal, and radical pro-
cedures are seldom needed. Radiotherapy is optional. The
disease is usually localized, but local recurrences are pos-
sible [34]. Metastasis is unusual, and death of disease is
rare. The overall prognosis of the patients is favorable.
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